TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT04596644

Impact of Repeatedly-Administered THC-cannabis on Experimental Pain and Abuse Liability in Humans

Cause of deathRegulatory or ethics Automatic label, confidence 0.9, unverified. How labels are made.
“In response to quality assurance and compliance concerns, OHRP issued an FWA restriction on NYSPI research that included a pause of human research as of June 23, 2023.”

The sponsor’s own words in the registry.

Life of this trial

20202021202220232024202520262027Registered2020-10-16Started2021-08-01Primary completion2024-08-31Suspended (as of)2026-09-24

Vital statistics

Status
Suspended
Phase
Phase 2
Sponsor
New York State Psychiatric Institute
Sponsor type
University, hospital or other
Conditions
Cannabis; Pain; Tolerance; Hyperalgesia
Interventions
Active Cannabis; Placebo Cannabis
Participants
16 (planned, not actual)
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.